Ravdin Peter M, Cronin Kathleen A, Howlader Nadia, Berg Christine D, Chlebowski Rowan T, Feuer Eric J, Edwards Brenda K, Berry Donald A
Department of Biostatistics, M.D. Anderson Cancer Center, Houston, USA.
N Engl J Med. 2007 Apr 19;356(16):1670-4. doi: 10.1056/NEJMsr070105.
An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply (by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 (omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor-positive than in those that were estrogen-receptor-negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded.
美国国立癌症研究所监测、流行病学和最终结果(SEER)登记处的初步数据分析显示,与2002年相比,2003年美国女性乳腺癌的年龄调整发病率大幅下降(6.7%)。2004年的数据显示,与2003年的发病率相比趋于平稳,几乎没有进一步下降。回归分析表明,下降始于2002年年中,并在2003年年中开始趋于平稳。比较2001年和2004年的发病率(省略发病率变化的年份)显示,年龄调整后的年发病率下降了8.6%(95%置信区间[CI],6.8至10.4)。这种下降仅在50岁及以上的女性中明显,在雌激素受体阳性的癌症中比在雌激素受体阴性的癌症中更明显。乳腺癌发病率的下降似乎在时间上与妇女健康倡议的首次报告以及美国绝经后妇女激素替代疗法使用量的随后下降有关。其他原因对发病率变化的影响似乎不太可能起主要作用,但也未被排除。